Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review

Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review

Abstract Background The emergence of immune checkpoint inhibitors (ICIs) has brought about a paradigm shift in cancer treatment as the use of these drugs has become more frequent and for a longer duration. As a result of T-cell-mediated inflammation at the programmed cell death-1, programmed death-l...

Full description

Bibliographic Details
Main Authors: Shingo Kazama, Ryota Morimoto, Yuki Kimura, Naoki Shibata, Reina Ozaki, Takashi Araki, Takashi Mizutani, Hideo Oishi, Yoshihito Arao, Tasuku Kuwayama, Hiroaki Hiraiwa, Toru Kondo, Kenji Furusawa, Tomoya Shimokata, Takahiro Okumura, Yasuko K. Bando, Yuichi Ando, Toyoaki Murohara
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Cardio-Oncology
Subjects:
Immune checkpoint inhibitors
Immune-related adverse events
Cardiotoxicity
Prognosis
Cardiovascular history
Online Access:https://doi.org/10.1186/s40959-021-00112-z

Internet

https://doi.org/10.1186/s40959-021-00112-z

Similar Items